“Which makes that 14 day possibility very intere
Post# of 148288
(Total Views: 803)
Posted On: 12/05/2020 9:16:37 PM
Re: Goosebumps #67081
“Which makes that 14 day possibility very interesting. Just sayin...”
Yes, 14 days is possible, but I don’t think it’s likely. The DSMC conducted the 50% interim analysis at 28 days and planned the 75% interim analysis at 28 days as well (they requested it at 42 days as well). Yes, NP said he’d talk to the DSMC about looking at the data at 14 days, but he also said an analysis at 50 patients would take place (which was never a possibility). I bring this up because NP has demonstrated in the past that he doesn’t quite understand the intricacies of clinical trials, thus, the DSMC viewing data at 14 days may not be a possibility. I’m not holding my breath but I’d welcome a nice PR before the CC as the sooner CYDY can apply for an EUA (with good date), the better for the world, for CYDY and for investors.
Yes, 14 days is possible, but I don’t think it’s likely. The DSMC conducted the 50% interim analysis at 28 days and planned the 75% interim analysis at 28 days as well (they requested it at 42 days as well). Yes, NP said he’d talk to the DSMC about looking at the data at 14 days, but he also said an analysis at 50 patients would take place (which was never a possibility). I bring this up because NP has demonstrated in the past that he doesn’t quite understand the intricacies of clinical trials, thus, the DSMC viewing data at 14 days may not be a possibility. I’m not holding my breath but I’d welcome a nice PR before the CC as the sooner CYDY can apply for an EUA (with good date), the better for the world, for CYDY and for investors.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼